Yet Another Value Podcast

Latest Episodes:

A roundtable on Angi $ANGI May 12, 2021

Show notes

Dickson Pau, Tom Moore, and Bill Henry, three first years at Columbia Business School, discuss their investment thesis for Angi. The three pitched ANGI in the Pershing Stock Challenge (placing second!), and they go into the due diligence they did putting their investment thesis together, the potential upside they see at ANGI, and all of the different risk factors they thought about.
The first Yet Another Value Podcast on ANGI: https://youtu.be/J2trsM41DTU
Spring Graham and Doddsville (ANGI pitch on p. 24): https://www8.gsb.columbia.edu/valueinvesting/sites/valueinvesting/files/Graham%20%20Doddsville_Issue%2042_v8.pdf
Tom's Twitter: https://twitter.com/FriarTom15
Dickson's Twitter: https://twitter.com/DicksonPau
Chapters
0:00 Intro and backgrounds
2:40 Why they chose ANGI for their pitch
7:10 Dickson's DD booking ANGI projects
15:00 Takeaways from ANGI expert calls
22:20 Fixed price: the most exciting piece of ANGI
28:30 How the team views ANGI's new CEO
36:20 Why hasn't ANGI hit their merger targets?
40:40 Is ANGI's near term decline in service requests concerning?
45:50 ANGI's struggles with service providers
52:20 Competition risk
57:00 Laying out the long term case for ANGI
1:00:30 Closing thoughts

Javier from Blind Squirrel discusses Netflix $NFLX May 04, 2021

Show notes

Javier Lovato from the Blind Squirrel comes on the podcast to discuss his post on Netflix, including why Netflix's scale is a massive moat, why the "Netflix doesn't do have quality" debate is wrong, and why Netflix is years ahead of their competition.
Blind Squirrel's Netflix Write Up: https://blindsquirrel.substack.com/p/netflix-focus-and-execution
Chapters
0:00 Intro
1:25 Why is Netflix a good investment?
7:25 Netflix's relationship with creators
14:05 Where is Netflix's Game of Thrones
21:50 Does Netflix's weak Q1 indicate competition is gaining on them?
39:30 Why'd Netflix stop disclosing churn?
41:35 Netflix cost of capital and share repurchases
48:15 Opportunity cost of Netflix versus Disney, Spotify, or legacy media
51:30 Does Netflix need to get into video games?

Neil Cataldi from Blueprint on Sanara Medtech $SMTI May 03, 2021

Show notes

Neil Cataldi from Blueprint Capital discusses his investment thesis for Sanara Medtech (SMTI). Sanara is growing quickly, and Neil thinks continued growth in their product portfolio and hospitals they are approved to sell in will drive continued accelerated growth and long term compounding.
Chapters
0:00 Intro
1:00 Sanara overview
5:30 How is Sanara increasing their hospital reach?
14:25 Discussing management
21:10 Related party risks
33:20 Breaking down SMTI's growth
42:45 Sanara's telehealth ambitions
1:01:10 Closing thoughts

Alex Morris from TSOH on Spotify $SPOT Apr 30, 2021

Show notes

Alex Morris, founder of The Science of Hitting, comes on the podcast to discuss his investment thesis for Spotify (SPOT). Topics include how Spotify can compete with larger competitors like Apple and Amazon, why Spotify is gaining the upper hand in negotiations with record labels, and how Spotify today rhymes with Netflix in the early stages of their streaming pivot.
The science of hitting substack: https://thescienceofhitting.substack.com/
Chapters
0:00 Intro
1:40 Why is Spotify a good investment?
4:40 How the past year built Alex's confidence in SPOT
7:55 Spotify as Netflix 2.0
11:30 Spotify's discover potential versus Netflix home page
13:40 Bear case #1: Competing with giants
17:35 Bear case #2: Lack of operating leverage and dealing with labels
22:10 Touching on the Taylor Swift re-recording
24:40 Bear case #3: Valuation
32:00 Bear case #4: Opportunity cost versus buying Twitter
37:40 Bear case #4 continued: Why not buy a label?
41:37 Live and podcast opportunity
46:10 Spotify's video opportunity
48:20 Content moderation issues
52:45 Spotify's concert and live event opportunity
55:45 What could Spotify acquire?
1:01:40 Alex's closing thoughts

Jeremy Raper goes activist on Hunter Douglas $HDG Apr 27, 2021

Show notes

Jeremy Raper, founder of Raper Capital (https://rapercapital.com/), makes his fourth podcast appearance to discuss his foray into activism at Hunter Douglas (HDG.NA). Hunter Douglas's controlling shareholder recently made an offer to take the company private that, to put it bluntly, vastly undervalues the business. Jeremy is pushing back on the deal and the process, and in this interview he explains why he's fighting the current offer and how he thinks the process will play out.
Jeremy's letter to the Hunter Douglas Board: https://rapercapital.com/2021/04/21/open-letter-to-the-independent-committee-of-the-board-of-hunter-douglas-n-v/
Chapters
0:00 Intro
1:30 Hunter Douglas Overview
3:05 Why is this a good business?
7:45 Performance in the pandemic and the blockbuster recovery
9:45 Framing the event
12:15 Simplifying the event even further
16:00 Valuation versus peers
22:45 Why is this process worse than a typically conflicted management buyout?
30:45 How the timing of the offer was unfair to minorities
35:45 A callback to the StoneX / Gain deal
39:25 How the process plays out post-acceptance period
45:15 Comping this deal to Collector's Universe
49:40 Discussing the squeeze out
51:30 Praising the poetry of Jeremy's letter
53:35 Jeremy and I hop on our horses about companies and regulators ignoring rules and laws
55:55 Closing thoughts

Ian Bezek on RenRen $RENN Apr 22, 2021

Show notes

Ian Bezek from Ian's Insider Corner discusses the most interesting event thesis I've seen this year: buying RenRen (RENN) into their legal battle over the OPI assets.
Ian's original RenRen write up: https://seekingalpha.com/article/4406707-renren-shareholders-claim-huge-sofi-stake-via-little-noticed-legal-fight
Ian's Twitter: https://twitter.com/irbezek
Chapters
0:00 Intro
1:05 RenRen Overview
2:25 How Ian discovered RenRen
3:50 OPI transaction background
6:40 Discussing OPI's valuation
8:15 Oasis (the lead plaintiff) and the attempt to reclaim value
9:45 Laying out the event path
11:45 Who would pay if Oasis / minority shareholders win?
16:05 What is the legal precedent here?
18:35 Quantifying the upside
21:50 If we win, what happens to RENN minority shareholders?
23:55 How SoFi getting adding as defendant changes the lawsuit
29:05 Does Chamath's history at CLOV impact the timing here?
32:00 Could RENN go into bankruptcy to void the lawsuits?
34:10 Valuing RENN's other assets
36:15 Closing thoughts

Francisco Olivera from Arevilo Capital on Roblox $RBLX Apr 20, 2021

Show notes

Francisco Olivera, founder of Arevilo Capital, discusses his newest investment in Roblox (RBLX). He covers his vision for the company, why he thinks it's more of a platform than a single game, and how he thinks the company will evolve over time.
Chapters
0:00 Intro
1:15 Roblox Overview
4:25 Comping Roblox to Minecraft and World of Warcraft
7:00 Defining the Roblox business model
11:35 Roblox valuation versus other game companies
18:45 Risk from Roblox's user base
26:25 Sustainability of Roblox's user base
29:38 Growing Roblox's DAU
34:00 Thinking about Roblox's COVID boost
37:00 Content moderation risk
42:00 Upside from Robux or messaging
49:10 Breaking down long term margins
52:40 Roblox's management team
57:15 Capital allocation going forward
59:55 Laying out a reasonable bull case
1:05:45 Quick Falcon and Winter Soldier catch up

Cove Street Capital on Viemed (VMD) Apr 19, 2021

Show notes

Eugene Robin and Andrew Leaf from Cove Street discuss their investment in Viemed. Viemed targets organic growth rates over 30%, yet the company only trades for ~15x free cash flow. Andrew and Eugene lay out their case for why the market is wrong on this one, including why VMD's business model is advantaged versus their competitors and why they aren't scare of a Medicare cut in the near to medium term.
Cove Street's first podcast appearance on Viasat (VSAT): https://youtu.be/Otw0oWvuhdU
Chapters
0:00 Intro
1:10 Viemed overview
4:30 Typical use case for VMD's ventilators
7:35 Discussion of COPD market
12:35 How VMD's business model is different than peers
24:20 Why is the market valuing a 30% organic growth business at 15x free cash flow?
33:20 Medicare cut risks and what happened in 2016
39:10 VMD's acquisition potential
42:00 VMD's moat with hiring therapists
47:00 Discussing VMD's bad debt expense
50:00 COVID's impact on VMD
53:30 Cove Street's price target
59:40 Parting thoughts

Adam Wilk from Greystone Capital on Liberated Syndication $LSYN Apr 14, 2021

Show notes

Adam Wilk, founder and portfolio manager at Greystone Capital, discusses his investment thesis in Liberated Syndication (LSYN). Key topics include why the company would make an attractive acquisition target, how Libsyn can grow in a competitive environment, and potential upside from a lawsuit that could cancel ~30% of LSYN's shares overnight.
Adam's Twitter account: https://twitter.com/AKWilk
Adam's LSYN thesis on seeking alpha: https://seekingalpha.com/article/4416747-liberated-syndication-update-and-favorable-developments
Chapters
0:00 Intro
1:15 Libsyn Overview
11:10 Libsyn Valuation
12:55 Libsyn vs. Competitors
19:35 Is Libsyn losing market share?
23:10 Comping Libsyn to Dropbox
29:10 The hunt for a new CEO
37:30 Could Spotify dominate podcast hosting like YouTube for video?
44:35 Upside from Libsyn's lawsuit to cancel shares

Yaron Naymark from 1 Main Capital on RCI Hospitality $RICK Apr 09, 2021

Show notes

Yaron Naymark, founder and Portfolio Manager at 1 Main Capital, discusses his investment in RCI Hospitality (RICK). RICK is a cash flow machine, and Yaron thinks the company is set to compound free cash flow per share at an accelerated rate for years as they continue to roll up the gentlemen's club industry at very low multiples, execute on their Bombshell's growth plans, and repurchase shares when they trade at attractive prices.
Yaron's Twitter: https://twitter.com/1MainCapital
1maincapital's website: https://www.1maincapital.com/
Chapters
0:00 Intro
1:55 RICK overview
10:05 Getting comfortable with the management team
18:30 Discussing the roll up opportunity
28:15 Valuation arbitrage on acquired clubs
32:25 Bombshell's growth prospects
38:50 Breaking down the ROIC for new Bombshell's
44:15 RICK valuation and SOTP
49:25 Does ESG and regulation help or hurt RICK?
51:55 Normalized FCF for RICK
57:10 Closing thoughts and adjusting for James Harden leaving Houston

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected